Deutsche Bank’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Deutsche Bank’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,705	Closed	-$132K	–	4054
2022 Q4	$132K	Buy	10,705 +2,309	+28%	+$55K	﹤0.01%	3196
2022 Q3	$276K	Buy	8,396 +2,726	+48%	+$77K	﹤0.01%	2748
2022 Q2	$107K	Sell	5,670 -1,124	-17%	-$21.5K	﹤0.01%	3494
2022 Q1	$120K	Buy	+6,794	New	+$139K	﹤0.01%	3518

Deutsche Bank's CINC Position: Q1 2023 in Review

Deutsche Bank sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 10,705 shares — an estimated $132K sold.

Deutsche Bank first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $276K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Deutsche Bank reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Deutsche Bank sold 10,705 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $132K.
Deutsche Bank first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Deutsche Bank's CinCor Pharma, Inc. Common Stock position peaked at $276K in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Deutsche Bank's 13F filing for Q1 2023, filed 15 May 2023.